Challenges to replace ACT as first-line drug
Abstract The spread of artemisinin and partner drug resistance through Asia requires changes in first-line therapy. The traditional modus has been the replacement of one first-line anti-malarial regimen with another. The number of anti-malarial drug candidates currently in development may have given...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2017-07-01
|
| Series: | Malaria Journal |
| Online Access: | http://link.springer.com/article/10.1186/s12936-017-1942-5 |